GenMont Biotech Incorporation

TWSE:3164.TW

22.85 (TWD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 32.99166.258139.42476.84775.54184.65231.231-219.457-83.55-381.03136.85719.8238.364155.83892.149
Depreciation & Amortization 64.7850.41521.13420.87321.23427.06439.72788.03395.777104.21717.75519.59623.23421.99519.938
Deferred Income Tax 000-11.7819.946-120.209-17.015188.83544.292000-79.8500
Stock Based Compensation 0000.0230.3451.3711.7541.8310.4949.8000.5800
Change In Working Capital -19.85147.677-19.03332.369-28.323-34.09628.893-10.76-67.576-22.57742.294-29.9131.08514.079-8.794
Accounts Receivables 11.5836.09-15.45629.7643.973-6.74120.9680.04-57.8050.1912.33110.969000
Inventory -31.669-18.2131.069-4.4799.32525.694-6.696-3.197-6.07917.1784.277-7.542-12.031-5.095-5.641
Accounts Payables -6.5142.9754.004-0.3170.203-16.2780.591-3.3554.775000000
Other Working Capital 6.74956.825-8.657.401-41.824-59.7935.589-7.563-61.497-39.75538.017-22.36843.11619.174-3.153
Other Non Cash Items -43.321-26.402-29.867-0.058-4.227-2.75-7.031-3.1455.553237.3953.465-34.74526.5248.1225.24
Operating Cash Flow 34.599137.948111.658118.27374.51556.03277.55945.337-5.01-61.996100.371-25.23939.937200.034108.533
Investing Activities:
Investments In Property Plant And Equipment -35.54-70.933-117.116-138.986-393.719-275.297-28.248-32.574-24.427-35.855-10.536-0.738-7.097-18.318-21.525
Acquisitions Net 0.2835.7983.53786.42933.841787.629-3.4850.080.921-693.30300.235000.18
Purchases Of Investments -406.435-300.55-61.496144.52-33.841-701.6-75.44964.654-190.89606.0120-46.05-11.20-57.9
Sales Maturities Of Investments 365.379286.932-0.175144.52366.8201.685-0.02364.6540-1.39682.645105.089103.13800.922
Other Investing Activites 0.939-4.95122.179-229.70431.337-13.843-15.9754.3340.8899.3850.8519.276-2.899-166.714-2.08
Investing Cash Flow -75.374-83.704-153.0716.7794.418-1.426-123.1836.414-214.428-115.15772.9667.81281.942-185.032-80.403
Financing Activities:
Debt Repayment -22.698-1.43-1.597-1.968-1.896-1.134-0.031-2.215-12.304-431.4-68.60000
Common Stock Issued 2.81400.669-0.8890.5200001,117.19900000.84
Common Stock Repurchased 45.39600-62.40000000000-13.589
Dividends Paid -60.46-95.008-49.215-70.258-133.36800000-30.456-65.061-130.123-53.314-53.315
Other Financing Activities -1.8695.3530.66986.18534.332.29133.318-0.4550-736.1430.051.68239.2555000
Financing Cash Flow -36.817-91.085-61.367-49.33-100.9342.29133.318-0.455-12.304-50.344-99.006-63.381109.132446.686-66.064
Other Information:
Effect Of Forex Changes On Cash -0.50.575-2.1137.454-11.621-1.7815.933-0.482-0.1650.3010.316-0.1710.399-0.3180
Net Change In Cash -78.092-36.266-104.89383.176-33.62255.116-6.3780.814-219.603-227.19674.641-20.979231.41461.37-37.934
Cash At End Of Period 55.595133.687169.953274.846191.67225.292170.176176.54695.732315.335542.5311,001.841,022.819791.409330.039